Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients

ABSTRACT Endothelial cells (EC) line the bone marrow microvasculature and are in close contact with CD8+ T cells that come and go across the permeable capillaries. Because of these intimate interactions, we investigated the capacity of EC to act as antigen-presenting cells (APC) and modulate CD8+ T cell activation and proliferation in bone marrow of patients with multiple myeloma (MM) and monoclonal gammopathy of undetermined significance. We found that EC from MM patients show a phenotype of semi-professional APC given that they express low levels of the co-stimulatory molecules CD40, CD80 and CD86, and of the inducible co-stimulator ligand (ICOSL). In addition, they do not undergo the strong switch from immunoproteasome to standard proteasome subunit expression which is typical of mature professional APC such as dendritic cells. EC can trap and present antigen to CD8+ T cells, stimulating a central memory CD8+ T cell population that expresses Foxp3 and produces high amounts of IL-10 and TGF-β. Another CD8+ T cell population is stimulated by professional APC, produces IFN-γ, and exerts antitumor activity. Thus, two distinct CD8+ T cell populations coexist in the bone marrow of MM patients: the first population is sustained by EC, expresses Foxp3, produces IL-10 and TGF-β, and exerts pro-tumor activity by negatively regulating the second population. This study adds new insight into the role that EC play in MM biology and describes an additional immune regulatory mechanism that inhibits the development of antitumor immunity and may impair the success of cancer immunotherapy.

[1]  Olga Mizrahi,et al.  Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and Research , 2018, Cytometry. Part B, Clinical cytometry.

[2]  T. Gebhardt,et al.  Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells , 2016, Front. Immunol..

[3]  F. Dammacco,et al.  Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing. , 2015, Blood.

[4]  R. Jordan,et al.  Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages , 2015, The Journal of Immunology.

[5]  G. Görgün,et al.  Targeting the bone marrow microenvironment in multiple myeloma , 2015, Immunological reviews.

[6]  F. Dammacco,et al.  MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. , 2013, Journal of the National Cancer Institute.

[7]  P. Couraud,et al.  The Brain Microvascular Endothelium Supports T Cell Proliferation and Has Potential for Alloantigen Presentation , 2013, PloS one.

[8]  F. Schildberg,et al.  Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice , 2012, Hepatology.

[9]  G. Grau,et al.  Antigen presentation by endothelial cells: what role in the pathophysiology of malaria? , 2012, Trends in parasitology.

[10]  V. Novakovic,et al.  Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells. , 2012, Blood.

[11]  Sabrina Bonomini,et al.  Angiogenesis and Multiple Myeloma , 2011, Cancer Microenvironment.

[12]  B. Scheithauer,et al.  Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. , 2011, Anticancer research.

[13]  M. Segal,et al.  Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus , 2010, Arthritis research & therapy.

[14]  A. Enk,et al.  Endothelial Cells Augment the Suppressive Function of CD4+CD25+Foxp3+ Regulatory T Cells: Involvement of Programmed Death-1 and IL-10 , 2010, The Journal of Immunology.

[15]  F. Dammacco,et al.  Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma. , 2010, Blood.

[16]  R. Schiffelers,et al.  Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. , 2008, Blood.

[17]  D. Ribatti,et al.  Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma , 2008, Oncogene.

[18]  P. Cresswell,et al.  A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. , 2006, Immunity.

[19]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[20]  D. Kreisel,et al.  Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[21]  H. Cho,et al.  Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. , 2005, Tissue antigens.

[22]  C. Harding,et al.  Mouse Endothelial Cells Cross-Present Lymphocyte-Derived Antigen on Class I MHC via a TAP1- and Proteasome-Dependent Pathway1 , 2005, The Journal of Immunology.

[23]  R. Bonasio,et al.  Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. , 2005, Immunity.

[24]  M. Dhodapkar,et al.  Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy , 2003, The Journal of experimental medicine.

[25]  R. Tampé,et al.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Davoust,et al.  ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.

[27]  Etienne Gagnon,et al.  Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.

[28]  Kenneth C. Anderson,et al.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group , 2003, British journal of haematology.

[29]  M. Dhodapkar,et al.  T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Stattin,et al.  Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer , 2002, The Prostate.

[31]  H. Ljunggren,et al.  Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance , 2000, Nature Medicine.

[32]  S. Fedosov,et al.  Functional analyses of two cellular binding domains of bovine lactadherin. , 2000, Biochemistry.

[33]  N. Shastri,et al.  Bacterial Proteins Can Be Processed by Macrophages in a Transporter Associated with Antigen Processing-Independent, Cysteine Protease-Dependent Manner for Presentation by MHC Class I Molecules1 , 2000, The Journal of Immunology.

[34]  A. Ramaswamy,et al.  Elevated expression of endoglin, a component of the TGF‐β‐receptor complex, correlates with proliferation of tumor endothelial cells , 1999, International journal of cancer.

[35]  A. Gazdar,et al.  Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  M. Kovacsovics-Bankowski,et al.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.

[37]  J. Pober,et al.  Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. , 1994, Journal of immunology.

[38]  D. Ribatti,et al.  Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis. , 2015, International review of cell and molecular biology.

[39]  R. Kyle,et al.  Multiple myeloma. , 2008, Blood.

[40]  A. Lichtman.  Endothelial Biomedicine: Endothelial Antigen Presentation , 2007 .

[41]  D. Kreisel,et al.  Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. , 2005, Journal of immunology.